
Listaspas 50mg/325mg Tablet
Marketer
Gavins Pharma Pvt Ltd
Salt Composition
Camylofin (50mg) + Paracetamol (325mg)
Overview Listaspas 50mg/325mg Tablet
Combiflam 50mg/325mg tablets offer relief from abdominal discomfort. This dual-action medication eases stomach and intestinal muscle spasms, thus reducing pain and cramping. It also inhibits pain and fever-inducing neurotransmitters. Administer Combiflam 50mg/325mg tablets as directed by your physician, with or without food. Dosage depends on individual response and condition; continued use as prescribed is crucial to prevent symptom recurrence and potential worsening. Inform your healthcare provider of all concurrent medications, as interactions may occur. Common, typically transient side effects include dry mouth, constipation, blurred vision, and tachycardia. Report any concerns to your doctor immediately. Dizziness and somnolence are possible; avoid driving or tasks requiring concentration until effects are known. Alcohol consumption should be avoided due to potential exacerbation of dizziness. Prior to commencing treatment, inform your doctor of pregnancy, pregnancy plans, breastfeeding, or existing kidney or liver conditions to ensure appropriate dosage.
Uses of Listaspas 50mg/325mg Tablet
Managing pain in the abdomen
Major Benefits of Listaspas 50mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg/325mg Listaspas tablet whole; avoid chewing, crushing, or breaking it. While food is not required, consistent timing is recommended for optimal results.
Common Side effects of Listaspas 50mg/325mg Tablet:
- Dryness in mouth
- Constipation
- Blurred vision
- Increased heart rate
How to use Listaspas 50mg/325mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the 50mg/325mg Listaspas tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended.
How Listaspas 50mg/325mg Tablet works:
Each Listaspas 50mg/325mg tablet combines camylofin and paracetamol to alleviate abdominal pain. Camylofin, an anticholinergic agent, diminishes stomach and intestinal muscle spasms, thereby easing cramps, bloating, and discomfort. Paracetamol, an analgesic and antipyretic, counteracts pain and fever by inhibiting the production of specific pain- and fever-inducing chemicals.
SAFETY ADVICE
AlcoholUNSAFE
Combining Listaspas 50mg/325mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Listaspas 50mg/325mg tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Listaspas 50mg/325mg tablets while breastfeeding are lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Listaspas 50mg/325mg Tablet on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Listaspas 50mg/325mg Tablets to individuals with advanced renal impairment; dosage modification may be necessary. Physician consultation is advised. Nevertheless, the paracetamol component of Listaspas 50mg/325mg Tablets is generally regarded as the safest analgesic option for patients with kidney disease.
LiverCAUTION
Patients with liver impairment should use Listaspas 50mg/325mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Listaspas 50mg/325mg tablets are contraindicated for individuals with severe or active liver disease.
What if you forget to take Listaspas 50mg/325mg Tablet :
Should you forget a Listaspas 50mg/325mg Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Listaspas 50mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal System |
